|
|
|
| Reducing Toxicities in Allogeneic Cell Therapies with Orca Bio's Dr. Scott McClellan | Orca Bio's CMO, Dr. Scott McClellan, joins Cell & Gene: The Podcast to discuss how and why toxicities continue to stymie allogeneic cell therapies. Learn about the company’s plan to potentially lower the risk of GvHD as well as Orca-T, the investigational high-precision allogeneic cell therapy being evaluated in clinical trials for the treatment of multiple hematologic malignancies. Listen now and subscribe so you never miss an episode! |
|
|
|
|
Can a small startup compete on the big obesity stage? Resalis hopes to bring a new mechanism, and new benefits, to the fight against obesity. |
|
|
|
Inspiring and nurturing the drug development leaders of tomorrow throughout their school years, early work experiences, and their careers helps patients, companies, and society at large. AstraZeneca's Renee Iacona provides the how and why. |
|
|
|
|
|
|
|
CONTRIBUTE TO LIFE SCIENCE LEADER |
|
|
|
Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director. |
|
|
| Connect With Life Science Leader: |
|
|
|
